Key Documents
Harvey Cohen
- Professor, Pediatrics
- Member, Bio-X
Contact Information
- Clinical Offices
Pediatric Hematology/Oncology 725 Welch Rd Palo Alto, CA 94304 Telephone Work (650) 497-8953 Fax (650) 497-8101
- Academic Offices
Personal Information Email punko@stanford.edu Tel (650) 736-7319, (650) 723-5131Not for medical emergencies or patient use
Clinical Focus
- Hematology, Pediatric
- Hematology/Oncology/Stem Cell Transplant, Pediatric
- Oncology (Cancer), Pediatric
- Pediatric Hematology-Oncology
Administrative Appointments
- Chair, Stanford University School of Medicine - Pediatrics , (1993– present )
Professional Education
- Boston Children's Hospital (1976) MA
- Boston Children's Hospital (1974) MA
- Boston Children's Hospital (1971) MA
- Duke University Medical Center (1970) NC
Postdoctoral Advisees
Web Site Links
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities.
- Service on Board of Directors: Morgridge Institute For Research
Research Interests
My research interests extend from hypothesis-driven studies in biochemistry and cell biology to discovery-driven interests in proteomics and systems biology to clinical treatment of acute lymphoblastic leukemia of children.
Our biochemical studies have centered on the identification and characterization of members of the glutathione peroxidase family of antioxidant enzymes that contain an enzymatically active selenocysteine residue within the primary structure of the protein.
Recently we have undertaken proteomic investigations whose aim is to identify differences in protein expression that may be biomarkers of diseases in children for which an unequivocal diagnostic test is unavailable, or there is little insight to the mechanism of the disease. This discovery-driven research is being used to identify proteins in plasma or urine of children with Kawasaki Disease, an inflammatory disorder that is the leading cause of acquired heart disease in the pediatric population. Other proteomic investigations are being performed in the areas of prematurity, neonatal disorders, acute lymphocytic and myelogenous leukemia, juvenile rheumatoid arthritis, and acquired respiratory distress syndromes.
My other clinical interests are found in hematologic and oncologic diseases of children, particularly acute lymphoblastic leukemia. Research is focused on optimization of multi-component chemotherapy and radiation treatment for these children. In addition, research investigations in pediatric palliative care have been initiated.
Publications
- Clin Immunol. 2008; (3): 438-47
- Pediatr Res. 2007; (2): 215-21
- Proteomics. 2005; (11): 2778-88
- Pediatrics. 2004; (5): 1248-52
- J Adolesc Health. 2003; (6): 403-4
- Prostate. 2003; (4): 315-21
- Am J Physiol Renal Physiol. 2002; (1): F20-8
- Mol Genet Metab. 2002; (3): 244-9
- Pediatr Res. 2002; (5): 641-6
- Arch Pediatr Adolesc Med. 2002; (1): 14-9
- Mol Cell Biochem. 2000; (1-2): 9-17
- Pediatr Res. 1999; (6): 715-21
- Mol Genet Metab. 1998; (3): 238-45
- Am J Physiol. 1998; (6 Pt 1): G1463-71
- Pediatr Res. 1996; (5): 902-13
- Blood. 1996; (10): 4325-32
- Arch Biochem Biophys. 1994; (2): 239-46
- Am J Physiol. 1994; (2 Pt 1): C367-75
- J Clin Oncol. 1993; (9): 1780-6